Immunocine Dendritic Cell Vaccine Protocol
Personalized double-loaded dendritic cell vaccine therapy pathway, including tissue preservation, patient preparation (reduced systemic inflammation, appropriate timing), and administration via image-guided injection near draining lymph nodes.
Assembled by Cited from Matt Halpert's recorded recommendations across multiple sources. It is not an ordered program and was not created or endorsed by them — it's our grouping of what they've said on the record.
Components
6-
Guest recommendation In a protocol
When tumor tissue is biopsied or resected, cryopreserve a portion rather than sending all of it to pathology in formaldehyde or paraffin, which destroys its usefulness for immunotherapy manufacturing.
“You don't want it to be dunked in formaldehyde or paraffin or fixatives, that actually destroys it.
TU▶ 40:00DosageCoordinate with surgeon in advance to save a portion of fresh tumor via cryopreservation before pathology fixation.CertaintyexplicitrecommendationCryopreserve tumor tissue at biopsy/resection — avoid formalin/paraffin fixation so it can be used to manufacture the vaccine. -
Guest recommendation In a protocol
Cryopreserve a sample of your tumor at the time of initial biopsy/surgery as a safeguard so personalized dendritic cell vaccine can be made later if conventional therapy fails or cancer relapses.
“Save some cancer.
TU▶ 1:05:00DosageRequest a kit from Immunocine Preserve; have surgeon place tumor tissue directly in provided solution tubes (avoid formaldehyde/paraffin fixatives) and ship overnight via FedEx.CaveatsMust be arranged before surgery/biopsy so the sample is not sent to pathology in fixative.Certaintyexplicitstrong endorsementImmunocine Preserve kit as the logistical mechanism for cryopreservation when biopsy/surgery happens outside Immunocine clinics. -
Guest recommendation In a protocol
Pursue dendritic cell vaccine therapy earlier in the cancer course (during stable disease, remission, or alongside standard care) rather than waiting until end-of-road relapse, since the immune response needs time to develop.
“The optimal time to do a treatment like this is not... let's wait till the last minute.
TU▶ 43:00CaveatsNot appropriate when prognosis is only weeks; may need to buy time with conventional care first.CertaintyexplicitrecommendationInitiate therapy early (stable disease, remission, or alongside standard care) — not at end-of-road when prognosis is only weeks. -
Guest recommendation In a protocol
Lower systemic inflammatory markers (LDH, CRP, ESR, RDW) before beginning dendritic cell vaccine therapy so the activated immune response can follow a gradient to the tumor rather than being lost in system-wide inflammation.
“Try to get your inflammation as under control as you can.
TU▶ 1:04:00DosageAddress markers such as LDH, CRP, ESR, RDW prior to treatment.CaveatsMust still allow a localized inflammatory response at the tumor site.CertaintyexplicitrecommendationReduce systemic inflammation (LDH, CRP, ESR, RDW) before vaccine administration so activated immune cells can follow a gradient to the tumor. -
Guest recommendation In a protocol
Personalized double-loaded dendritic cell vaccine therapy from the patient's own tumor tissue, used to train the immune system to recognize and attack cancer; available via FDA trials (glioblastoma, pancreatic ductal adenocarcinoma, refractory melanoma) and via Immunocine clinics in Cancun and Cabo for other cases.
“Turn your immune system on, get it in the game.
TU▶ 1:00:00DosageBiopsy tumor tissue (cryopreserved, not formalin-fixed), manufacture personalized DC vaccine, administer via image-guided injection near functional draining lymph nodes; three or more shots depending on protocol.CaveatsNot a guarantee of cure; not ideal if patient has weeks to live, uncontrolled systemic inflammation, or no residual tumor to sample; FDA trials limited to specific cancers in US.Certaintyexplicitstrong endorsementAdminister the double-loaded dendritic cell vaccine via image-guided injection near functional draining lymph nodes; three or more shots. -
Guest recommendation In a protocol
Apply at immunocine.com for a free case review to determine whether dendritic cell vaccine therapy is appropriate; separate immunocinepreserve.com for tumor cryopreservation logistics.
“We don't really charge for... give us a shot. Send us your record, send us your scans.
TU▶ 1:06:00DosageSubmit records and scans for free review; set up private call if candidate.CaveatsInclusion criteria apply; not everyone is accepted.CertaintyexplicitrecommendationEntry point / case review via immunocine.com to determine candidacy.
How this protocol has evolved
Protocol evolved from ~2011-2012 lab discovery of the 'double-loading' MHC Class I + Class II mechanism, through FDA-fast-tracked trials (glioblastoma, pancreatic ductal adenocarcinoma, refractory melanoma) in the US, and parallel Immunocine clinics in Cancun and Cabo for patients outside trial criteria. Immunocine Preserve was added as a safeguard service so tissue would be available if conventional therapy succeeded initially but cancer later relapsed.